Elevance Health (Elevance Health) GF Value : $554.21 (As of Apr. 26, 2024)

View and export this data going back to 2001. Start your Free Trial

What is Elevance Health GF Value?

The GF Value represents the current intrinsic value of a stock derived from our exclusive method. The GF Value Line on our summary page gives an overview of the fair value that the stock should be traded at. It is calculated based on three factors:

Historical multiples (PE Ratio, PS Ratio, PB Ratio and Price-to-Free-Cash-Flow) that the stock has traded at.
GuruFocus adjustment factor based on the company’s past returns and growth.
Future estimates of the business performance.

We believe the GF Value Line is the fair value that the stock should be traded at. The stock price will most likely fluctuate around the GF Value Line. If the stock price is significantly above the GF Value Line, it is overvalued and its future return is likely to be poor. On the other hand, if it is significantly below the GF Value Line, its future return will likely be higher.

Please note, "Possible Value Trap, Think Twice" is for the companies that look very undervalued, but either in the long term trend of business decline, or in financial distress.

As of today (2024-04-26), Elevance Health's share price is $539.195. Elevance Health's GF Value is $554.21. Therefore, Elevance Health's Price-to-GF-Value for today is 0.97.

Based on the relationship between the current stock price and the GF Value, GuruFocus believes Elevance Health is Fairly Valued.

Elevance Health (NYSE:ELV) GF Value Explanation

Based on the relationship between the current stock price and the GF Value, GuruFocus provides the following 6 evaluations:

Posssible Evaluations	All-in-One Screener Examples (2)
Possible Value Trap, Think Twice (1)	Predictable Companies that possibly be Value Traps
Significantly Overvalued	Predictable Companies which are Significantly Overvalued
Modestly Overvalued	Predictable Companies which are Modestly Overvalued
Fairly Valued	Predictable High Quality Companies which are Fairly Valued
Modestly Undervalued (3)	Predictable High Quality Companies which are Modestly Undervalued
Significantly Undervalued (3)	Predictable High Quality Companies which are Significantly Undervalued

(1) "Possible Value Trap, Think Twice" is for the companies that look very undervalued, but either in the long term trend of business decline, or in financial distress.

(2) These are some simple examples. You can access our GF Valuation filter under All-in-One Screener’s Fundamental tab, and Price-to-GF-Value filter under Valuation Ratio tab and set your own criteria.

(3) There is only a sufficient margin of safety when the stock is undervalued.

Elevance Health's Price-to-GF-Value for today is calculated as

Price-to-GF-Value	=	Share Price	/	GF Value
	=	539.195	/	554.21
	=	0.97

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Elevance Health GF Value Related Terms

Thank you for viewing the detailed overview of Elevance Health's GF Value provided by GuruFocus.com. Please click on the following links to see related term pages.

Elevance Health (Elevance Health) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Healthcare Plans » Elevance Health Inc (NYSE:ELV) » Definitions » GF Value

Comparable Companies

Traded in Other Exchanges

ELV:Mexico A58:Germany A58:Germany

Address

220 Virginia Avenue, Indianapolis, IN, USA, 46204

Website

https://www.elevancehealth.com

Elevance Health remains one of the leading health insurers in the U.S., providing medical benefits to 48 million medical members as of June 2023. The company offers employer, individual, and government-sponsored coverage plans. Elevance differs from its peers in its unique position as the largest single provider of Blue Cross Blue Shield branded coverage, operating as the licensee for the Blue Cross Blue Shield Association in 14 states. Through acquisitions, such as the Amerigroup deal in 2012 and MMM in 2021, Elevance's reach expands beyond those states through government-sponsored programs such as Medicaid and Medicare Advantage plans, too.

Executives

Blair Williams Todt	officer: EVP and Chief Legal Officer	8735 HENDERSON ROAD, TAMPA FL 33625
Ronald W Penczek	officer: SVP, Chief Accounting Officer	120 MONUMENT CIRCLE, INDIANAPOLIS IN 46204
Mark Kaye	officer: EVP & CFO Designate	7 WORLD TRADE CENTER, 250 GREENWICH ST, NEW YORK NY 10007
Dixon Robert L Jr	director	120 MONUMENT CIRCLE, INDIANAPOLIS IN 46204
Gloria M Mccarthy	officer: EVP, Office of the CEO	WELLPOINT, INC, 120 MONUMENT CIRCLE, INDIANAPOLIS IN 46204
Kendrick Charles Morgan Jr	officer: EVP & President, Commercial	220 VIRGINIA AVE, INDIANAPOLIS IN 46204
Deanna D Strable-soethout	director	C/O PRINCIPAL FINANCIAL GROUP, 711 HIGH ST., DES MOINES IA 50392
Ramiro G Peru	director	WELLPOINT, INC, 120 MONUMENT CIRCLE, INDIANAPOLIS IN 46260
Peter D Haytaian	officer: EVP & Pres., Govt. Bus. Div.	220 VIRGINIA AVE, INDIANAPOLIS IN 46204
Susan D. Devore	director	C/O PREMIER, INC., 13034 BALLANTYNE CORPORATE PLACE, CHARLOTTE NC 28277
Ryan M. Schneider	director	1680 CAPITAL ONE DRIVE, MCLEAN VA 22102
John E Gallina	officer: SVP & Chief Accounting Officer	120 MONUMENT CIRCLE, INDIANAPOLIS IN 46204
Julie A Hill	director	WELLPOINT, INC, 120 MONUMENT CIRCLE, INDIANAPOLIS IN 46204
Thomas C Zielinski	officer: EVP & General Counsel
Jeffrey D. Alter	officer: EVP, IngenioRx & Anthem Health	4330 LA JOLLA VILLAGE DRIVE, SUITE 200, SAN DIEGO CA 92122